<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boikos C</submitter><funding>Seqirus (United States)</funding><funding>Seqirus</funding><pagination>896</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9228909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(6)</volume><pubmed_abstract>The adaptation of influenza seed viruses in egg culture can result in a variable antigenic vaccine match each season. The cell-based quadrivalent inactivated influenza vaccine (IIV4c) contains viruses grown in mammalian cell lines rather than eggs. IIV4c is not subject to egg-adaptive changes and therefore may offer improved protection relative to egg-based vaccines, depending on the degree of match with circulating influenza viruses. We summarize the relative vaccine effectiveness (rVE) of IIV4c versus egg-based quadrivalent influenza vaccines (IIV4e) to prevent influenza-related medical encounters (IRMEs) from three retrospective observational cohort studies conducted during the 2017-2018, 2018-2019, and 2019-2020 US influenza seasons using the same underlying electronic medical record d</pubmed_abstract><journal>Vaccines</journal><pubmed_title>Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons.</pubmed_title><pmcid>PMC9228909</pmcid><funding_grant_id>NA</funding_grant_id><pubmed_authors>Boikos C</pubmed_authors><pubmed_authors>Molrine D</pubmed_authors><pubmed_authors>Ortiz JR</pubmed_authors><pubmed_authors>Puig-Barbera J</pubmed_authors><pubmed_authors>McGovern I</pubmed_authors><pubmed_authors>Haag M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons.</name><description>The adaptation of influenza seed viruses in egg culture can result in a variable antigenic vaccine match each season. The cell-based quadrivalent inactivated influenza vaccine (IIV4c) contains viruses grown in mammalian cell lines rather than eggs. IIV4c is not subject to egg-adaptive changes and therefore may offer improved protection relative to egg-based vaccines, depending on the degree of match with circulating influenza viruses. We summarize the relative vaccine effectiveness (rVE) of IIV4c versus egg-based quadrivalent influenza vaccines (IIV4e) to prevent influenza-related medical encounters (IRMEs) from three retrospective observational cohort studies conducted during the 2017-2018, 2018-2019, and 2019-2020 US influenza seasons using the same underlying electronic medical record d</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-19T17:38:05.941Z</modification><creation>2025-04-19T17:38:05.941Z</creation></dates><accession>S-EPMC9228909</accession><cross_references><pubmed>35746504</pubmed><doi>10.3390/vaccines10060896</doi></cross_references></HashMap>